annual CFF:
$213.03M+$33.01M(+18.33%)Summary
- As of today (July 11, 2025), SLNO annual cash flow from financing activities is $213.03 million, with the most recent change of +$33.01 million (+18.33%) on December 31, 2024.
- During the last 3 years, SLNO annual CFF has risen by +$213.15 million (+166525.78%).
- SLNO annual CFF is now at all-time high.
Performance
SLNO Cash from financing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly CFF:
$3.22M-$53.84M(-94.36%)Summary
- As of today (July 11, 2025), SLNO quarterly cash flow from financing activities is $3.22 million, with the most recent change of -$53.84 million (-94.36%) on March 31, 2025.
- Over the past year, SLNO quarterly CFF has increased by +$2.28 million (+243.07%).
- SLNO quarterly CFF is now -97.89% below its all-time high of $152.75 million, reached on June 30, 2024.
Performance
SLNO quarterly CFF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM CFF:
$215.31M+$2.28M(+1.07%)Summary
- As of today (July 11, 2025), SLNO TTM cash flow from financing activities is $215.31 million, with the most recent change of +$2.28 million (+1.07%) on March 31, 2025.
- Over the past year, SLNO TTM CFF has increased by +$34.35 million (+18.98%).
- SLNO TTM CFF is now -32.00% below its all-time high of $316.65 million, reached on June 30, 2024.
Performance
SLNO TTM CFF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Cash from financing Formula
CFF = Cash Inflows from Financing Activities − Cash Outflows from Financing Activities
SLNO Cash from financing Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +18.3% | +243.1% | +19.0% |
| 3 y3 years | +10000.0% | -77.1% | +1434.7% |
| 5 y5 years | +1371.1% | +10000.0% | +214.6% |
SLNO Cash from financing Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | >+9999.0% | -97.9% | +1241.1% | -32.0% | >+9999.0% |
| 5 y | 5-year | at high | >+9999.0% | -97.9% | +1241.1% | -32.0% | >+9999.0% |
| alltime | all time | at high | >+9999.0% | -97.9% | +1241.1% | -32.0% | >+9999.0% |
SLNO Cash from financing History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2025 | - | $3.22M(-94.4%) | $215.31M(+1.1%) |
| Dec 2024 | $213.03M(+18.3%) | $57.06M(+2408.3%) | $213.03M(-23.8%) |
| Sep 2024 | - | $2.27M(-98.5%) | $279.52M(-11.7%) |
| Jun 2024 | - | $152.75M(>+9900.0%) | $316.65M(+75.0%) |
| Mar 2024 | - | $938.00K(-99.2%) | $180.96M(+0.5%) |
| Dec 2023 | $180.02M(+1177.5%) | $123.56M(+213.6%) | $180.02M(+218.8%) |
| Sep 2023 | - | $39.40M(+131.0%) | $56.46M(+224.5%) |
| Jun 2023 | - | $17.06M(>+9900.0%) | $17.40M(>+9900.0%) |
| Mar 2023 | - | $0.00(0.0%) | $60.00K(-99.6%) |
| Dec 2022 | $14.09M(<-9900.0%) | $0.00(-100.0%) | $14.09M(+0.0%) |
| Sep 2022 | - | $342.00K(-221.3%) | $14.09M(+2.5%) |
| Jun 2022 | - | -$282.00K(-102.0%) | $13.74M(-2.0%) |
| Mar 2022 | - | $14.03M(<-9900.0%) | $14.03M(<-9900.0%) |
| Dec 2021 | -$128.00K(-100.2%) | -$5000.00(<-9900.0%) | -$128.00K(-22.4%) |
| Sep 2021 | - | $0.00(-100.0%) | -$165.00K(-54.2%) |
| Jun 2021 | - | $2000.00(-101.6%) | -$360.00K(-100.7%) |
| Mar 2021 | - | -$125.00K(+197.6%) | $53.60M(-0.2%) |
| Dec 2020 | $53.72M(+271.0%) | -$42.00K(-78.5%) | $53.72M(-21.3%) |
| Sep 2020 | - | -$195.00K(-100.4%) | $68.25M(-0.3%) |
| Jun 2020 | - | $53.96M(<-9900.0%) | $68.44M(+372.7%) |
| Mar 2020 | - | -$4000.00(-100.0%) | $14.48M(-0.0%) |
| Dec 2019 | $14.48M(-18.8%) | $14.48M(>+9900.0%) | $14.48M(-11.2%) |
| Sep 2019 | - | $0.00(0.0%) | $16.30M(-4.1%) |
| Jun 2019 | - | $0.00(0.0%) | $17.00M(-3.1%) |
| Mar 2019 | - | $0.00(-100.0%) | $17.54M(-1.6%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2018 | $17.83M(-26.2%) | $16.30M(+2228.9%) | $17.83M(+13.6%) |
| Sep 2018 | - | $700.00K(+30.4%) | $15.70M(+4.7%) |
| Jun 2018 | - | $537.00K(+86.5%) | $14.99M(+3.7%) |
| Mar 2018 | - | $288.00K(-98.0%) | $14.46M(-40.2%) |
| Dec 2017 | $24.17M(+124.5%) | $14.17M(>+9900.0%) | $24.17M(+141.7%) |
| Sep 2017 | - | $0.00(0.0%) | $10.00M(-36.3%) |
| Jun 2017 | - | $0.00(-100.0%) | $15.70M(-0.4%) |
| Mar 2017 | - | $10.00M(>+9900.0%) | $15.77M(+46.4%) |
| Dec 2016 | $10.77M(+17.6%) | $100.00(-100.0%) | $10.77M(-28.0%) |
| Sep 2016 | - | $5.70M(+8040.0%) | $14.95M(+41.5%) |
| Jun 2016 | - | $70.00K(-98.6%) | $10.56M(-2.0%) |
| Mar 2016 | - | $5.00M(+19.5%) | $10.78M(+17.7%) |
| Dec 2015 | $9.16M(-18.3%) | $4.18M(+219.7%) | $9.16M(-36.6%) |
| Sep 2015 | - | $1.31M(+364.2%) | $14.45M(+9.0%) |
| Jun 2015 | - | $282.00K(-91.7%) | $13.26M(-9.1%) |
| Mar 2015 | - | $3.38M(-64.3%) | $14.59M(+30.2%) |
| Dec 2014 | $11.20M(>+9900.0%) | $9.48M(+7866.4%) | $11.20M(+550.2%) |
| Sep 2014 | - | $119.00K(-92.6%) | $1.72M(+7.4%) |
| Jun 2014 | - | $1.60M(>+9900.0%) | $1.60M(>+9900.0%) |
| Mar 2014 | - | $0.00(0.0%) | $0.00(0.0%) |
| Dec 2013 | $0.00(-100.0%) | $0.00(-100.0%) | $0.00(0.0%) |
| Sep 2013 | - | -$200.00(-200.0%) | $0.00(-100.0%) |
| Jun 2013 | - | $200.00(>+9900.0%) | $200.00(>+9900.0%) |
| Mar 2013 | - | $0.00 | $0.00 |
| Dec 2012 | $5.03M | - | - |
FAQ
- What is Soleno Therapeutics, Inc. annual cash flow from financing activities?
- What is the all time high annual CFF for Soleno Therapeutics, Inc.?
- What is Soleno Therapeutics, Inc. annual CFF year-on-year change?
- What is Soleno Therapeutics, Inc. quarterly cash flow from financing activities?
- What is the all time high quarterly CFF for Soleno Therapeutics, Inc.?
- What is Soleno Therapeutics, Inc. quarterly CFF year-on-year change?
- What is Soleno Therapeutics, Inc. TTM cash flow from financing activities?
- What is the all time high TTM CFF for Soleno Therapeutics, Inc.?
- What is Soleno Therapeutics, Inc. TTM CFF year-on-year change?
What is Soleno Therapeutics, Inc. annual cash flow from financing activities?
The current annual CFF of SLNO is $213.03M
What is the all time high annual CFF for Soleno Therapeutics, Inc.?
Soleno Therapeutics, Inc. all-time high annual cash flow from financing activities is $213.03M
What is Soleno Therapeutics, Inc. annual CFF year-on-year change?
Over the past year, SLNO annual cash flow from financing activities has changed by +$33.01M (+18.33%)
What is Soleno Therapeutics, Inc. quarterly cash flow from financing activities?
The current quarterly CFF of SLNO is $3.22M
What is the all time high quarterly CFF for Soleno Therapeutics, Inc.?
Soleno Therapeutics, Inc. all-time high quarterly cash flow from financing activities is $152.75M
What is Soleno Therapeutics, Inc. quarterly CFF year-on-year change?
Over the past year, SLNO quarterly cash flow from financing activities has changed by +$2.28M (+243.07%)
What is Soleno Therapeutics, Inc. TTM cash flow from financing activities?
The current TTM CFF of SLNO is $215.31M
What is the all time high TTM CFF for Soleno Therapeutics, Inc.?
Soleno Therapeutics, Inc. all-time high TTM cash flow from financing activities is $316.65M
What is Soleno Therapeutics, Inc. TTM CFF year-on-year change?
Over the past year, SLNO TTM cash flow from financing activities has changed by +$34.35M (+18.98%)